Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ870,58710,35
KB805,5806,50,69
PKN56,1456,161,12
Msft430,3430,79-0,16
Nokia3,9443,948-0,43
IBM222,9223,23-0,18
Mercedes-Benz Group AG59,6759,683,40
PFE29,0129,020,21
27.09.2024 12:22:55
Indexy online
AD Index online
select
AD Index online
 

  • 26.09.2024
Avinger Rg (NASDAQ Cons)
Závěr k 26.9.2024 Změna (%) Změna (USD) Objem obchodů (ks)
0,97 -3,00 -0,03 40 324
Premarket27.09.2024 12:17:16
Poslední obchod Nákup / Prodej Změna (%) Změna (USD) Objem obchodů (ks)
- 0,95 0,9694 - - -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 27.09.2024
Popis společnosti
Obecné informace
Název společnostiAvinger Inc
TickerAVGR
Kmenové akcie:Ordinary Shares
RICAVGR.O
ISIN-
Prioritní akcieConv. Pref. Shrs
Prioritní akcieConv. Pref. Shrs Series E
Prioritní akcieConv. Pref. Shrs Series F
Poslední známé roční výsledky31.12.2023
Poslední známé čtvrtletní výsledky30.06.2024
Počet zaměstnanců k 31.12.2023 68
Akcie v oběhu k 30.06.2024 2 296 146
MěnaUSD
Kontaktní informace
Ulice400 Chesapeake Dr
MěstoREDWOOD CITY
PSČ94063-4739
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon16 503 632 400
Fax13026555049

Business Summary: Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
Financial Summary: BRIEF: For the six months ended 30 June 2024, Avinger Inc revenues decreased 6% to $3.7M. Net loss applicable to common stockholders decreased 26% to $8.3M. Revenues reflect United States segment decrease of 5% to $3.4M, Germany segment decrease of 18% to $259K. Basic Earnings per Share excluding Extraordinary Items increased from -$19.55 to -$5.30.
Odvětvová klasifikace
TRBC2009Medical Equipment / Supplies / Distribution
TRBC2012Medical Imaging Systems
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICS2007Electromedical Apparatus Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
SICElectromedical Equipment
SICSurgical And Medical Instruments



  • Poslední aktualizace: 27.09.2024
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorJeffrey Soinski61
Chief Financial Officer, Chief Accounting Officer, Vice President - FinanceNabeel Subainati4021.07.202221.07.2022
Chief Technology OfficerHimanshu Patel64